Trials / Conditions / Lung Cancer Stage IV

Lung Cancer Stage IV

23 registered clinical trials studyying Lung Cancer Stage IV — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Screening for Brain Metastases NCT07492121	University of Zurich	Phase 2
Withdrawn	Re-induction of a Systemic Immune Response in Metastatic or Locally Recurrent Lung Cancer NCT06024941	Maastricht Radiation Oncology	Phase 2
Recruiting	Characteristics of Advanced LUNG CANCER at the tIme of Diagnosis in a Large Italian Cohor NCT06076005	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	—
Unknown	Prognostic Value of Combined Approach Based on KEAP1/NFE2L2 Mutations and Pre-therapeutic FDG-PET/CT Radiomic NCT05996263	University Hospital, Brest	—
Terminated	Testing Experimental Anti-cancer Drug SLC-391 With an Approved Immunotherapy Drug, Pembrolizumab, for Advanced NCT05860296	SignalChem Lifesciences Corporation	Phase 1 / Phase 2
Unknown	The Effect of Combined Cryotherapy and Immunotherapy on Systemic T Cell Changes and Clinical Outcomes in Metas NCT06000358	Lithuanian University of Health Sciences	N/A
Unknown	Lazertinib 160mg in EGFR T790M NSCLC NCT05701384	Samsung Medical Center	Phase 2
Unknown	Psychosocial eHealth in Advanced Lung Cancer NCT05497973	Institut Català d'Oncologia	N/A
Unknown	Sotorasib in Advanced KRASG12C-mutated Non-small Cell Lung Cancer Patients With Comorbidities NCT05311709	Vestre Viken Hospital Trust	Phase 2
Unknown	Efficacy of SRT as Salvage Therapy in Patients With Brain Oligo-progression of EGFR-mutant Non-small Cell Lung NCT04519983	Shanghai Cancer Hospital, China	Phase 2
Withdrawn	Stereotactic Body Radiotherapy for Lung Lesions With Markerless Tracking (MLT) on the VERO® SBRT System NCT06722885	Universitair Ziekenhuis Brussel	—
Completed	Resilience Measurement in Older Adults With Late-Stage Lung Cancer NCT04825912	Duke University	N/A
Terminated	Comparing Different Sizes of Small-bore Chest Drains in Malignant Pleural Effusion NCT04669223	The University of Hong Kong	N/A
Completed	Self-System Therapy for Older Adults With Lung Cancer NCT04057196	Duke University	N/A
Unknown	Liver Toxicity in Lung Cancer Patients Treated With Immune-checkpoint Inhibitors. NCT04595734	Western Sydney Local Health District	—
Withdrawn	Personalizing Immune Checkpoint Inhibitor Therapy NCT03409341	Holy Cross Hospital, Maryland	—
Active Not Recruiting	Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advance NCT03728361	Dwight Owen	Phase 2
Unknown	A Study of SHR-1210 in Combination With Carboplatin + Paclitaxel in Subjects With Squamous NSCLC NCT03668496	Jiangsu HengRui Medicine Co., Ltd.	Phase 3
Completed	Feasibility of a Web-based Patient Reported Outcome Symptom Monitoring Application in Danish Lung Cancer Patie NCT03529851	Regional Hospital West Jutland	N/A
Completed	Lung Cancer Next Generation Sequencing Using the Oncomine Comprehensive Assay NCT03558165	University Health Network, Toronto	—
Unknown	Calypso Guided High Precision Stereotactic Ablative Radiosurgery for Lung TUmours Using Real-Time Tumour Track NCT03322072	CancerCare Manitoba	N/A
Unknown	Icotinib Combined With SBRT for Patients With Metastatic Non-squamous NSCLC With EGFR Mutation NCT03153358	Sichuan Cancer Hospital and Research Institute	Phase 2
Completed	A Phase 1/2 Trial of Trametinib and Erlotinib in Patients With EGFR-Mutant Lung Adenocarcinomas and Acquired R NCT03076164	Memorial Sloan Kettering Cancer Center	Phase 1 / Phase 2